Imagine if you were suffering from MND/ALS.
You know that Monepantel works to slow down MND/ALS in humans, but you can't buy it yet.
Meanwhile, you read that the FDA is delaying approval, by asking about Monepantel's safety in animals.
What is going on?
Ann: FDA Guidance on NUZ-001 IND Application, page-52
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $81.23M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.5¢ | $23.56K | 141.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 30232 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 13227 | 2 |
View Market Depth
| Last trade - 15.37pm 24/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |